EMGRAF 1MG CAPSULE belongs to a class of drugs called immunosuppressants used to prevent rejection of a transplanted organ such as a liver, kidney, or heart. Organ rejection occurs when a patient’s immune system recognizes the donor organ as foreign and tries to eliminate it.

EMGRAF 1MG CAPSULE contains Tacrolimus, which works by suppressing the activity of T and B lymphocytes (cells in the immune system) that normally attacks foreign invaders and defend the body against foreign cells and infection. Thus, prevents organ rejection in transplanted patients and helps the body in accepting the new organ.

Take EMGRAF 1MG CAPSULE as prescribed. You are advised to use EMGRAF 1MG CAPSULE for as long as your doctor has recommended it for you based on your medical condition. Some people may experience nausea, diarrhoea, headache, kidney problems, infection, fever, constipation or high blood pressure. Most of these side effects of EMGRAF 1MG CAPSULE do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

If you are allergic to Tacrolimus or any other medicines, please tell your doctor. If you are pregnant or a breastfeeding mother, it is advised to consult a doctor before using EMGRAF 1MG CAPSULE. Avoid alcohol consumption with EMGRAF 1MG CAPSULE. Drive only if you are alert, as EMGRAF 1MG CAPSULE may cause some people vision problems or nervous disturbances. If you are about to get vaccinated, inform your doctor before taking EMGRAF 1MG CAPSULE. EMGRAF 1MG CAPSULE may increase the risk of infections or skin cancer as it lowers the body’s immune defence system.

EMGRAF 1MG CAPSULE contains Tacrolimus, an immunosuppressant used to prevent organ rejection after a transplant. EMGRAF 1MG CAPSULE suppresses the activity of T and B lymphocytes (cells in the immune system) that normally attacks foreign invaders and defend the body against foreign cells and infection. As a result, it helps the body accept the new organ and prevents organ rejection in patients who have had organ transplants.

Please tell your doctor if you are allergic to Tacrolimus or other medicines. If you are pregnant or a breastfeeding mother, it is advised to consult a doctor before using EMGRAF 1MG CAPSULE. Avoid alcohol consumption with EMGRAF 1MG CAPSULE. Drive only if you are alert, as EMGRAF 1MG CAPSULE may cause vision problems or nervous disturbances in some people. If you are about to get vaccinated, inform your doctor before taking EMGRAF 1MG CAPSULE. EMGRAF 1MG CAPSULE may increase the risk of infections or skin cancer as it lowers the body’s immune defence system. While taking EMGRAF 1MG CAPSULE, you are advised to wear protective clothing and sunscreen while going out. You are recommended to use glass or metal materials to prepare the oral suspension. Avoid using plastic (PVC) materials to prepare the suspension as the granules will stick to a plastic container, and your child may not receive their full dose. Do not inhale or let the granules or prepared oral suspension come in contact with your skin or eyes. In case of accidental contact with skin, wash the area well with soap and water, and if it comes in contact with the eyes, rinse with plain water.

Regular blood tests and certain other tests are recommended while taking EMGRAF 1MG CAPSULE to check blood sugar levels, kidney functioning and potassium levels in the blood.